ORIC
ORIC Pharmaceuticals Inc

790
Mkt Cap
$787.39M
Volume
5.57M
52W High
$14.93
52W Low
$3.90
PE Ratio
-4.64
ORIC Fundamentals
Price
$8.04
Prev Close
$8.09
Open
$8.16
50D MA
$11.75
Beta
1.45
Avg. Volume
1.18M
EPS (Annual)
-$1.83
P/B
1.92
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 7.5% - Here's What Happened
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 7.5% - Here's What Happened...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Oric Pharmaceuticals, Inc. $ORIC Shares Sold by EcoR1 Capital LLC
EcoR1 Capital LLC decreased its position in shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 52.7% during the second quarter, according to its most recent 13F filing with the...
MarketBeat·7d ago
News Placeholder
Stempoint Capital LP Makes New Investment in Oric Pharmaceuticals, Inc. $ORIC
Stempoint Capital LP purchased a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
Vivo Capital LLC Has $31.74 Million Stock Holdings in Oric Pharmaceuticals, Inc. $ORIC
Vivo Capital LLC lifted its stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 50.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·11d ago
News Placeholder
Resolute Capital Asset Partners LLC Invests $2.31 Million in Oric Pharmaceuticals, Inc. $ORIC
Resolute Capital Asset Partners LLC acquired a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and...
MarketBeat·11d ago
News Placeholder
Oric Pharmaceuticals' (ORIC) Outperform Rating Reaffirmed at Wedbush
Wedbush reissued an "outperform" rating and set a $20.00 price target on shares of Oric Pharmaceuticals in a report on Monday...
MarketBeat·12d ago
News Placeholder
JPMorgan Chase & Co. Raises Stake in Oric Pharmaceuticals, Inc. $ORIC
JPMorgan Chase & Co. increased its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 3,646.1% during the 2nd quarter, according to the company in its most recent 13F filing with...
MarketBeat·12d ago
News Placeholder
Geode Capital Management LLC Trims Stock Position in Oric Pharmaceuticals, Inc. $ORIC
Geode Capital Management LLC lowered its stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 15.1% during the second quarter, according to the company in its most recent filing with...
MarketBeat·16d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of Oric Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·27d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Should You Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Time to Buy...
MarketBeat·29d ago
<
1
2
...
>

Latest ORIC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.